Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | GNX102 |
Synonyms | |
Therapy Description |
GNX102 is a monoclonal antibody targeting the Lewis B and Lewis Y glycans, which may lead to antibody-dependent cellular cytotoxicity (ADCC) against tumor cells expressing these glycans (NCI Drug Dictionary). |